Tucuvi joins Microsoft Pegasus Program to scale clinical voice AI

Tucuvi, an AI care management company, has joined the Microsoft for Startups Pegasus Program, which connects startups to Microsoft's enterprise customers and go-to-market channels. According to the company, health systems and life sciences firms can now contract Tucuvi through Microsoft Marketplace or count the spend against their existing Azure commitment.
- Tucuvi has joined the Microsoft for Startups Pegasus Program, announced Oct. 15, 2026.
- Health systems and life sciences firms can buy via Microsoft Marketplace or use their existing Azure commitment.
- Its LOLA® clinical voice AI agent integrates with Microsoft Foundry and Azure Speech.
- More than 80 health settings run 50+ workflow types on the platform, according to Tucuvi.
- The technology is certified as Class IIb Software as a Medical Device in the European Union.
A procurement path through Microsoft
Tucuvi announced on Oct. 15, 2026 that it is part of the Microsoft for Startups Pegasus Program. The company says the move comes as it scales its platform across health systems, and that Pegasus will let it bring its clinically governed approach to AI care management to more organizations.
The release stresses a practical benefit for buyers. Health systems and life sciences companies can contract Tucuvi directly through Microsoft Marketplace, or apply that spend against the Microsoft Azure commitment they have already made. According to Tucuvi, this turns a new vendor evaluation into a purchase against budget that is already allocated, through a procurement path the organization has already approved.
Tom Davis, General Manager of Microsoft for Startups, said the initiative gives select startups access to Microsoft Azure's AI models, enterprise-grade security and privacy, and go-to-market support.
Access and clinical care on one platform
Tucuvi argues that health systems evaluating patient-facing AI increasingly want one platform covering both patient access and clinical enablement. Access includes scheduling, navigation and referral routing. Clinical enablement covers care-gap closure, medication adherence, transitions of care, monitoring and follow-up.
The company describes these as fundamentally different problems. In access, success means getting patients to the right service. In clinical care, AI must reliably follow protocols, capture clinically relevant information and escalate the right cases to clinicians. Tucuvi says it was built from the clinical side and later expanded into access. Today, more than 80 health settings run 50+ workflow types on the platform.
How LOLA and Tucuvi Health Manager work
Tucuvi Health Manager is the company's AI care management platform. At its core is LOLA®, a clinical voice AI agent that holds inbound and outbound phone conversations with patients in natural language. LOLA follows configurable clinical and administrative protocols, captures structured information and escalates cases when human intervention is required. The platform is omnichannel and can extend the same workflows to text.
On the Microsoft side, LOLA integrates with Microsoft Foundry, used as the platform layer for deploying and monitoring the models behind its conversational capabilities, and with Azure Speech for the voice layer of patient conversations. Care teams can configure protocols, manage escalations, coordinate workflows and connect to existing EHRs, CRMs and call center systems. The platform also shows program performance, including reach, engagement, escalations and workflow outcomes, so teams can adjust programs while they are live.
Health systems and payers run LOLA across several workflows:
- Post-discharge follow-up and Transitional Care Management (TCM)
- Chronic Care Management (CCM) and monitoring check-ins
- Care-gap closure and quality outreach, including medication adherence
- Pharmacy operations, such as prescription refills
- Patient access workflows, such as scheduling
Clinical governance and safety
Tucuvi says clinical governance is built into the platform. Organizations can use evidence-based protocols or configure their own, define escalation criteria and workflow actions, and keep oversight of patient interactions and clinical decisions.
The company says its technology is developed to medical-device safety standards and is certified as Class IIb Software as a Medical Device in the European Union, which it describes as a level of clinical validation that remains uncommon among patient-facing voice AI platforms.
CEO and co-founder María González Manso said health systems are not asking whether the agent sounds natural. In her words, the questions are "who defines the protocol, what happens when a patient says something that needs a clinician, and whether the same thing happens on every call."
What it means for health systems
For health organizations already committed to Azure, the main change is commercial: according to Tucuvi, they can buy its platform through an existing Microsoft relationship rather than start a separate procurement process. For Tucuvi, the program offers access to Microsoft's enterprise customer ecosystem. González Manso said Pegasus lets the company bring its model "to more health systems, faster."

